The state has devoted $100 million – with an additional $35 million of SSBCI funding – to the New York State Innovation Venture Capital Fund, a direct investment fund for Seed through Series B technology companies across New York State.   

Investment Criteria   

We invest in exceptional founders from diverse backgrounds who solve large-scale problems using innovative technologies in the following sectors: Climate Technology, Health Tech and Life Sciences, Ag-tech Systems, Advanced Manufacturing, social impact SaaS, Data, and AI and other critical technologies. 

Approach  

Stage: Primarily Seed and Series A rounds  

Co-investment: We invest alongside your lead institutional or strategic investor but do not lead rounds ourselves.  

Commitment   

Our companies make a commitment to building a diverse workforce in New York State, generating new jobs and other economic activity. We also consider companies willing to relocate to New York.  

New York Ventures is actively deploying capital through the New York State Innovation Venture Capital Fund and is proud to support a diverse and growing portfolio of companies.  

Portfolio Exits    

Artemis (acquired by iUNU), GiveGab (acquired by EveryAction), Seamless Docs (acquired by Kofile), Concertio (acquired by Synopsys), Kinvolved (acquired by PowerSchool), Tara Biosystems (acquired by Valo Health), RedPin Therapeutics (acquired by Kriya Therapeutics) , The Cru (acquired by We Are Luminary), MyndYou.

Email New York Ventures at: [email protected]